Top 5 overall and No. 1 for babies again, Children’s National named to U.S. News & World Report’s 2018-19 Best Children’s Hospitals Honor Roll
Al Jalila Children’s and Children’s National Sign International Health Information Technology Agreement
The new connection will equip UAE’s first children’s hospital to effectively use health information technology for the benefit of patients.
Children’s National Medical Center has been named a Leapfrog Group Top Hospital for 2017; one of only 10 children’s hospitals in the United States and the only one in the mid-Atlantic region. This is the ninth time that Children’s National has earned this prestigious designation given to hospitals with distinct achievements in patient safety and quality including lower infection rates, decreased lengths of stay and fewer readmissions.
Children’s National becomes first pediatric medical institution in the United States to receive combined FACT accreditation related to cellular immunotherapy
The new Foundation for the Accreditation of Cellular Therapy (FACT) accreditation highlights Children’s National leadership and excellence in bone marrow transplants and cell therapies. Considered the threshold for excellence in cellular therapy, FACT establishes standards for high-quality medical and laboratory practice in the field.
Children’s National Medical Center experts to present at 49th Congress of the International Society of Paediatric Oncology (SIOP)
Leading pediatric oncology experts at Children’s National Medical Center joined thousands of their peers in Washington, D.C., for the 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15, 2017.
The grade school student has been a patient for a while, but during a routine visit, 9-year-old Pedro finally confides that he has had headaches and difficulty concentrating in school for weeks now. The scenario is among the case studies that Olanrewaju Falusi, M.D., F.A.A.P., and a colleague explained during their presentation, ”Advancing health care quality for immigrant children,” during the 2017 American Academy of Pediatrics (AAP) national conference.
Study successfully uses facial analysis technology developed at Children’s National to identify Noonan syndrome in diverse populations
Researchers have successfully used facial analysis software to identify Noonan syndrome in diverse populations, according to an international study published in the Sept. 2017 issue of the American Journal of Medical Genetics.
A new approach to treating children diagnosed with bilateral Wilms tumors (BWT) significantly improved event-free survival (EFS), or the length of time a patient does not experience complications or recurrence of cancer following treatment, and overall survival (OS) rates after four years when compared to historical rates, according to a Children’s Oncology Group study published in the September 2017 issue of the Annals of Surgery.
New published study shows incisionless surgery with MR-HIFU highly effective in destroying painful bone tumors
Doctors from the Sheikh Zayed Institute for Pediatric Surgical Innovation have completed a clinical trial that demonstrates how osteoid osteoma, a benign but painful bone tumor that commonly occurs in children and young adults, can be safely and successfully treated using an incisionless surgery method called magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU).
Women and girls with autism may face greater challenges with real world planning, organization and other daily living skills, according to a study published in the journal Autism Research.
Ranked #1 for babies and Top 10 overall, Children’s National Medical Center earns national recognition in U.S. News & World Report 2017-18 Best Children’s Hospitals Survey
Children’s National is proud to be named #1 for newborn intensive care in the U.S. News & World Report Best Children’s Hospitals survey and ranked among the Top 10 children’s hospitals overall. What makes us the best choice for care in the nation’s capital? Expertise that’s focused on children’s unique needs and support for every family.
Children’s National Medical Center has been recognized by HIMSS Analytics for reaching Stage 6 status on the EMR Adoption ModelSM (EMRAM), an achievement reached by only 32 percent of the nation’s more than 5,400 hospitals. Serving children and families in the Washington area for nearly 150 years, Children’s National Medical Center is a renowned leader in pediatric medicine and recognized globally for the development and implementation of innovative treatments.
Children’s National proprietary robotic surgical technology Smart Tissue Autonomous Robot (STAR) has been named one of the top 10 finalists in the 2017 NASA iTech call for ideas challenge.
Children’s National Medical Center only Washington, DC, hospital again named to Becker’s Hospital Review 100 Great Hospitals in America
Children’s National Medical Center was the only Washington, D.C., hospital named to Becker’s Hospital Review 100 Great Hospitals in America for the second consecutive year.
New study successfully uses facial analysis technology developed at Children’s National to diagnose rare genetic disease
Facial analysis software can assist clinicians in making accurate diagnosis of 22q1.2 deletion syndrome (also called DiGeorge syndrome), according to an international study published in the April 2017 issue of the American Journal of Medical Genetics.
Children’s National Medical Center experts to present data on novel approach to cell therapy for cancer patients
Emerging data from Children’s National Medical Center are providing hope that a new approach to cell therapy may effectively harness the cancer-killing potential of the natural immune system as a treatment for patients with blood and bone marrow cancers for whom stem cell transplantation has not worked.
Children’s National Medical Center announces the creation of first-of-its-kind Rare Disease Institute
Children's National Medical Center, the nation’s largest provider of care for children with rare genetic disorders, announced it has formed the Children’s National Rare Disease Institute (CNRDI), a first-of-its-kind center focused exclusively on advancing the care and treatment of children and adults with rare genetic diseases.
Children’s National announced the creation of an integrated team that is dedicated to working with patients with autism spectrum disorder, their families and their medical care teams to create customized plans to address each child’s unique needs.